The presence of <i>KMT2A/AFF1</i> rearrangement in B-lymphoblastic leukemia (B-ALL) is an independent poor prognostic factor and has been associated with higher rate of treatment failure and higher risk of linage switch under therapy. The gene discussed is AFF1; the disease is acute lymphoblastic leukemia.